MichaelFredrickKelleyMD

PubMed

• Metabolism and excretion of canagliflozin in mice, rats, dogs, and humans.
  Mamidi RNVS, Cuyckens F, Chen J, Scheers E, Kalamaridis D, Lin R, Silva J, Sha S, Evans DC, Kelley MF, Devineni D, Johnson MD, Lim HK> ;Drug Metab. Dispos.. 2014-05-01
• Implications of retinal effects observed in chronic toxicity studies on the clinical development of a CNS-active drug candidate.
  Eichenbaum, G.,Zhou, J.,Kelley, M. F.,Roosen, W.,Costa-Giomi, P.,Louden, C.,Diprospero, N.,Pandina, G.,Singh, J.,Ford, L.,Moyer, J.,Nork, T. M.,Ver Hoeve, J. N.,Aguirr...> ;Regul. Toxicol. Pharmacol.. 2014 Apr 01
• Oxidative stress/reactive metabolite gene expression signature in rat liver detects idiosyncratic hepatotoxicants.
  Leone, A.,Nie, A.,Brandon Parker, J.,Sawant, S.,Piechta, L. A.,Kelley, M. F.,Mark Kao, L.,Jim Proctor, S.,Verheyen, G.,Johnson, M. D.,Lord, P. G.,McMillian, M. K.> ;Toxicol. Appl. Pharmacol.. 2014 Feb 04
• Leading medical causes of mortality among male prisoners in Texas, 1992--2003.
  Harzke, A.J., Baillargeon, J.G., Kelley, M.F., Pruitt, S.L., Pulvino, J.S., Paar, D.P.> ;J Correct Health Care. 2011 Jul
• Gavage-related reflux in rats: identification, pathogenesis, and toxicological implications (review).
  Damsch S, Eichenbaum G, Tonelli A, Lammens L, Van den Bulck K, Feyen B, Vandenberghe J, Megens A, Knight E, Kelley M> ;Toxicol Pathol. 2011-02-01
• Unexpected nasal changes in rats related to reflux after gavage dosing.
  Damsch S, Eichenbaum G, Looszova A, Lammens L, Feyen B, Van den Bulck K, Knight E, Kelley M, Tonelli A> ;Toxicol Pathol. 2011-02-01
• Prevalence of chronic medical conditions among inmates in the Texas prison system.
  Harzke, A.J., Baillargeon, J.G., Pruitt, S.L., Pulvino, J.S., Paar, D.P., Kelley, M.F.> ;J Urban Health. 2010 May
• HCV-related mortality among male prison inmates in Texas, 1994-2003.
  Harzke, A.J., Baillargeon, J.G., Kelley, M.F., Diamond, P.M., Goodman, K.J., Paar, D.P.> ;Ann Epidemiol. 2009-08-01
• Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
  Mamidi, R.S., Mannens, G., Annaert, P., Hendrickx, J., Goris, I., Bockx, M., Janssen, C.M., Kao, M., Kelley, M.F., Meuldermans, W.> ;Drug Metab Dispos. 2007 Apr
• Evaluation of felbamate and other antiepileptic drug toxicity potential based on hepatic protein covalent binding and gene expression.
  Leone, A.M., Kao, L.M., McMillian, M.K., Nie, A.Y., Parker, J.B., Kelley, M.F., Usuki, E., Parkinson, A., Lord, P.G., Johnson, M.D.> ;Chem Res Toxicol. 2007 Apr
• Pharmacokinetic considerations and efficacy of levofloxacin in an inhalational anthrax (postexposure) rhesus monkey model.
  Kao, L.M., Bush, K., Barnewall, R., Estep, J., Thalacker, F.W., Olson, P.H., Drusano, G.L., Minton, N., Chien, S., Hemeryck, A., Kelley, M.F.> ;Antimicrob Agents Chemother. 2006 Nov
• Methicillin-resistant Staphylococcus aureus infection in the Texas prison system.
  Baillargeon, J., Kelley, M.F., Leach, C.T., Baillargeon, G., Pollock, B.H.> ;Clin Infect Dis. 2004 May 1
• Promotion of colon tumors in C57BL/6J-APC(min)/+ mice by thiazolidinedione PPARgamma agonists and a structurally unrelated PPARgamma agonist.
  Pino, M.V., Kelley, M.F., Jayyosi, Z.> ;Toxicol Pathol. 2004-01-01
• Catalytic and immunochemical characterization of cytochrome P450 isozyme induction in dog liver.
  Jayyosi Z, Muc M, Erick J, Thomas PE, Kelley M> ;Fundam Appl Toxicol. 1996-05-01
• Induction of peroxisomal enzymes by a tetrazole-substituted 2-quinolinylmethoxy leukotriene D4 antagonist.
  Kelley M, Groth-Watson A, Knoble D, Kornbrust D> ;Fundam Appl Toxicol. 1994-08-01
• Controlling tuberculosis in minority populations in Texas.
  Wallace CE, Kelley MF, Bybee JA> ;Tex Med. 1991-10-01
• Hib vaccine is available and soon to be required.
  Kelley MF> ;Tex Med. 1991-01-01
• The effect of pretreatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic metabolism of 2,4,5-trichlorophenoxyacetate (2,4,5-T) and 2,4-dichlorophenoxyacetate...
  Kelley M, Vessey DA> ;Toxicol. Appl. Pharmacol.. 1987-11-01
• TB transmission in hospitals.
  Kelley, M. F.> ;Healthtexas. 1992 Jan 01
• Evaluating rabies exposure.
  Kelley, M. F., Mahlow, J. C.> ;Tex Med. 2001 Apr
• Outbreak of histoplasmosis among cavers attending the National Speleological Society Annual Convention, Texas, 1994.
  Ashford, D. A., Hajjeh, R. A., Kelley, M. F., Kaufman, L., Hutwagner, L., McNeil, M. M.> ;Am J Trop Med Hyg. 1999 Jun
• The absorption, metabolism, and excretion of the novel neuromodulator RWJ-333369 (1,2-ethanediol, [1-2-chlorophenyl]-, 2-carbamate, [S]-) in humans.
  Mannens, G. S., Hendrickx, J., Janssen, C. G., Chien, S., Van Hoof, B., Verhaeghe, T., Kao, M., Kelley, M. F., Goris, I., Bockx, M., Verreet, B., Bialer, M., Meulderma...> ;Drug Metab Dispos. 2007 Apr
• Subchronic toxicity studies with the leukotriene D4 antagonist RG 12525.
  Bonnefoi, M. S., Kelley, M. F., Wells, R. E., Sanders, J. E., Jayyosi, Z., Beys, E., Kornbrust, D. J., Langloss, J. M.> ;Fundam Appl Toxicol. 1995 Nov
• Impact of gavage dosing procedure and gastric content on adverse respiratory effects and mortality in rat toxicity studies.
  Eichenbaum, G., Damsch, S., Looszova, A., Vandenberghe, J., Van den Bulck, K., Roels, K., Megens, A., Knight, E., Hillsamer, V., Feyen, B., Kelley, M. F., Tonelli, A.,...> ;J Appl Toxicol. 2011 May
• Pharmacokinetics, metabolism, excretion and plasma protein binding of 14C-levofloxacin after a single oral administration in the Rhesus monkey.
  Hemeryck, A., Mamidi, R. N., Bottacini, M., Macpherson, D., Kao, M., Kelley, M. F.> ;Xenobiotica. 2006 Jul
• Join now to see all